• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲临床实践环境中传统心血管危险因素的超额风险 - EURIKA 研究。

Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

出版信息

BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704.

DOI:10.1186/1471-2458-11-704
PMID:21923932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3184074/
Abstract

BACKGROUND

Physicians involved in primary prevention are key players in CVD risk control strategies, but the expected reduction in CVD risk that would be obtained if all patients attending primary care had their risk factors controlled according to current guidelines is unknown. The objective of this study was to estimate the excess risk attributable, firstly, to the presence of CVD risk factors and, secondly, to the lack of control of these risk factors in primary prevention care across Europe.

METHODS

Cross-sectional study using data from the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA), which involved primary care and outpatient clinics involved in primary prevention from 12 European countries between May 2009 and January 2010. We enrolled 7,434 patients over 50 years old with at least one cardiovascular risk factor but without CVD and calculated their 10-year risk of CVD death according to the SCORE equation, modified to take diabetes risk into account.

RESULTS

The average 10-year risk of CVD death in study participants (N = 7,434) was 8.2%. Hypertension, hyperlipidemia, smoking, and diabetes were responsible for 32.7 (95% confidence interval 32.0-33.4), 15.1 (14.8-15.4), 10.4 (9.9-11.0), and 16.4% (15.6-17.2) of CVD risk, respectively. The four risk factors accounted for 57.7% (57.0-58.4) of CVD risk, representing a 10-year excess risk of CVD death of 5.66% (5.47-5.85). Lack of control of hypertension, hyperlipidemia, smoking, and diabetes were responsible for 8.8 (8.3-9.3), 10.6 (10.3-10.9), 10.4 (9.9-11.0), and 3.1% (2.8-3.4) of CVD risk, respectively. Lack of control of the four risk factors accounted for 29.2% (28.5-29.8) of CVD risk, representing a 10-year excess risk of CVD death of 3.12% (2.97-3.27).

CONCLUSIONS

Lack of control of CVD risk factors was responsible for almost 30% of the risk of CVD death among patients participating in the EURIKA Study.

摘要

背景

参与初级预防的医生是 CVD 风险控制策略的关键参与者,但如果所有接受初级保健的患者都按照当前指南控制其风险因素,那么预期可以降低多少 CVD 风险尚不清楚。本研究的目的是首先估计 CVD 风险因素的存在以及其次,在欧洲初级预防护理中,这些风险因素控制不佳会导致多少额外风险。

方法

这是一项使用 2009 年 5 月至 2010 年 1 月期间来自欧洲心血管风险预防和管理日常实践研究(EURIKA)的数据进行的横断面研究,该研究涉及 12 个欧洲国家的初级保健和门诊诊所。我们招募了 7434 名年龄在 50 岁以上、至少有一个心血管风险因素但没有 CVD 的患者,并根据 SCORE 方程计算他们的 10 年 CVD 死亡风险,该方程经过修改以考虑糖尿病风险。

结果

研究参与者(N=7434)的平均 10 年 CVD 死亡风险为 8.2%。高血压、高血脂、吸烟和糖尿病分别导致 32.7%(95%置信区间 32.0-33.4)、15.1%(14.8-15.4)、10.4%(9.9-11.0)和 16.4%(15.6-17.2)的 CVD 风险。这四个风险因素占 CVD 风险的 57.7%(57.0-58.4),代表 10 年 CVD 死亡的超额风险为 5.66%(5.47-5.85)。高血压、高血脂、吸烟和糖尿病控制不佳分别导致 8.8%(8.3-9.3)、10.6%(10.3-10.9)、10.4%(9.9-11.0)和 3.1%(2.8-3.4)的 CVD 风险。这四个风险因素控制不佳占 CVD 风险的 29.2%(28.5-29.8),代表 10 年 CVD 死亡的超额风险为 3.12%(2.97-3.27)。

结论

EURIKA 研究参与者中 CVD 风险因素控制不佳导致近 30%的 CVD 死亡风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a44/3184074/a0d8760b7387/1471-2458-11-704-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a44/3184074/a1d818073051/1471-2458-11-704-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a44/3184074/a0d8760b7387/1471-2458-11-704-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a44/3184074/a1d818073051/1471-2458-11-704-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a44/3184074/a0d8760b7387/1471-2458-11-704-2.jpg

相似文献

1
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.欧洲临床实践环境中传统心血管危险因素的超额风险 - EURIKA 研究。
BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704.
2
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA).EURIKA 研究:欧洲日常实践中心血管风险预防与管理的原理和方法。
BMC Public Health. 2010 Jun 30;10:382. doi: 10.1186/1471-2458-10-382.
3
Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA study.希腊心血管疾病一级预防:EURIKA 研究的希腊结果。
Hellenic J Cardiol. 2014 May-Jun;55(3):217-26.
4
Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.德国心血管疾病风险预防与管理的障碍——EURIKA研究分析
Vasc Health Risk Manag. 2012;8:177-86. doi: 10.2147/VHRM.S29915. Epub 2012 Mar 15.
5
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.在欧洲的临床实践中实现心血管疾病一级预防的治疗目标:EURIKA 研究。
Eur Heart J. 2011 Sep;32(17):2143-52. doi: 10.1093/eurheartj/ehr080. Epub 2011 Apr 6.
6
Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.在阿卜杜勒阿齐兹国王大学医院的普通诊所就诊的高危人群中的心血管危险因素:一项横断面研究。
BMC Cardiovasc Disord. 2019 Nov 27;19(1):268. doi: 10.1186/s12872-019-1261-6.
7
Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study.欧洲原发性心血管疾病预防中高血压控制不佳:EURIKA研究结果
Int J Cardiol. 2016 Sep 1;218:83-88. doi: 10.1016/j.ijcard.2016.05.044. Epub 2016 May 13.
8
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.欧洲心血管疾病一级预防中致动脉粥样硬化性血脂异常的患病率及治疗情况:EURIKA横断面观察性研究
BMC Cardiovasc Disord. 2017 Jun 17;17(1):160. doi: 10.1186/s12872-017-0591-5.
9
Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study.医生控制心血管风险因素的实践调查:EURIKA 研究。
Eur J Prev Cardiol. 2012 Jun;19(3):541-50. doi: 10.1177/1741826711407705. Epub 2011 Apr 18.
10
Management of cardiovascular risk factors for primary prevention: evaluation of Turkey results of the EURIKA study.原发性预防中心血管危险因素的管理:欧洲心血管疾病预防研究(EURIKA)土耳其研究结果评估
Turk Kardiyol Dern Ars. 2012 Mar;40(2):135-42. doi: 10.5543/tkda.2012.01827.

引用本文的文献

1
Cardiovascular risk assessment of dyslipidemic middle-aged adults without overt cardiovascular disease over the period of 2009-2016 in Lithuania.2009-2016 年期间立陶宛无明显心血管疾病的血脂异常中年成年人的心血管风险评估。
Lipids Health Dis. 2018 Oct 11;17(1):233. doi: 10.1186/s12944-018-0883-5.
2
Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS).男性心血管疾病一级预防的危险因素控制:来自阿拉贡工人健康研究(AWHS)的证据。
PLoS One. 2018 Feb 23;13(2):e0193541. doi: 10.1371/journal.pone.0193541. eCollection 2018.
3
Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.

本文引用的文献

1
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.糖尿病、空腹血糖浓度与血管疾病风险:102 项前瞻性研究的协作荟萃分析。
Lancet. 2010 Jun 26;375(9733):2215-22. doi: 10.1016/S0140-6736(10)60484-9.
2
Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA).EURIKA 研究:欧洲日常实践中心血管风险预防与管理的原理和方法。
BMC Public Health. 2010 Jun 30;10:382. doi: 10.1186/1471-2458-10-382.
3
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
动脉粥样硬化性心血管疾病与抗逆转录病毒疗法
Curr HIV/AIDS Rep. 2016 Oct;13(5):297-308. doi: 10.1007/s11904-016-0331-y.
4
Glycaemic control, treatment satisfaction and quality of life in type 2 diabetes patients in Greece: The PANORAMA study Greek results.希腊 2 型糖尿病患者的血糖控制、治疗满意度和生活质量:PANORAMA 研究希腊结果。
World J Diabetes. 2015 Feb 15;6(1):208-16. doi: 10.4239/wjd.v6.i1.208.
5
Lack of blood pressure control in Italy: room for improvement?意大利血压控制不佳:是否有改进空间?
High Blood Press Cardiovasc Prev. 2015 Mar;22(1):1-3. doi: 10.1007/s40292-014-0076-x. Epub 2014 Dec 3.
6
Simulating the impact of improved cardiovascular risk interventions on clinical and economic outcomes in Russia.模拟改善心血管疾病风险干预措施对俄罗斯临床和经济结果的影响。
PLoS One. 2014 Aug 20;9(8):e103280. doi: 10.1371/journal.pone.0103280. eCollection 2014.
7
Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation-The POWER Survey.降压治疗对SCORE评估的总体心血管风险的影响:一项开放标签、多国研究——POWER调查的结果
Int J Hypertens. 2013;2013:165789. doi: 10.1155/2013/165789. Epub 2013 Jul 25.
8
Do family physicians advise younger people on cardiovascular disease prevention? A cross-sectional study from Slovenia.家庭医生是否为年轻人提供心血管疾病预防建议?来自斯洛文尼亚的一项横断面研究。
BMC Fam Pract. 2013 Jun 14;14:82. doi: 10.1186/1471-2296-14-82.
9
Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.在糖尿病减肥临床试验 LOOK AHEAD(糖尿病健康行动)中,对心血管疾病危险因素、抑郁症状和抗抑郁药物使用进行了为期 4 年的分析。
Diabetes Care. 2013 May;36(5):1088-94. doi: 10.2337/dc12-1871. Epub 2013 Jan 28.
10
High prevalence and diminished awareness of overweight and obesity in a mediterranean population. An alarming call for action.地中海人群中超重和肥胖的高患病率及认知度降低。行动的警钟敲响。
Open Cardiovasc Med J. 2012;6:141-6. doi: 10.2174/1874192401206010141. Epub 2012 Nov 16.
欧洲动脉粥样硬化研究项目III。全科医疗中无症状高危患者心血管危险因素的管理:12个欧洲国家的横断面调查。
Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40. doi: 10.1097/HJR.0b013e3283383f30.
4
The global burden of diabetes and its complications: an emerging pandemic.糖尿病及其并发症的全球负担:一场新出现的大流行。
Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S3-8. doi: 10.1097/01.hjr.0000368191.86614.5a.
5
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.执行摘要:《2010年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2010 Feb 23;121(7):948-54. doi: 10.1161/CIRCULATIONAHA.109.192666.
6
Diagnosis and classification of diabetes mellitus.糖尿病的诊断与分类
Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S62-9. doi: 10.2337/dc10-S062.
7
Major lipids, apolipoproteins, and risk of vascular disease.主要脂质、载脂蛋白与血管疾病风险
JAMA. 2009 Nov 11;302(18):1993-2000. doi: 10.1001/jama.2009.1619.
8
Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.脂质治疗评估项目2:一项评估实现低密度脂蛋白胆固醇目标的患者比例的跨国调查。
Circulation. 2009 Jul 7;120(1):28-34. doi: 10.1161/CIRCULATIONAHA.108.838466. Epub 2009 Jun 22.
9
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.日常实践中的心血管疾病预防指南:八个欧洲国家的EUROASPIRE I、II和III调查比较
Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5.
10
The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status.自我报告吸烟情况的准确性:对自我报告吸烟状况与可替宁评估吸烟状况之间关系的系统评价。
Nicotine Tob Res. 2009 Jan;11(1):12-24. doi: 10.1093/ntr/ntn010. Epub 2009 Jan 27.